Status:

COMPLETED

Association of Mood With Risk for Atherosclerosis

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Mood Disorders

Hypertension

Eligibility:

All Genders

Up to 22 years

Brief Summary

The investigators will aim to determine the association of mood disorders (MDO) with preclinical and clinical cardiovascular (CVD) risk factors among children. The investigators will also aim to iden...

Detailed Description

This research is being done to determine if mood disorders in children have an impact on stiffness of arteries and/or cause the arteries to not work as well and if MDOs impact blood pressure over a 24...

Eligibility Criteria

Inclusion

  • Children Ages ≤ 22 years old
  • Enrolled in the CHAMPION Trial and have agreed to be contacted for future studies or children who visit PMP clinic and have MDO and a healthy weight or participants in the Be-HealthY Cohort whose data indicate no history of MDO.

Exclusion

  • Not able to speak English
  • Unable to lie supine
  • Significant Arrhythmia
  • If participant has used vaso-active drugs the morning of the test (tobacco, caffeine decongestants, or asthma medications).

Key Trial Info

Start Date :

March 11 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 31 2022

Estimated Enrollment :

37 Patients enrolled

Trial Details

Trial ID

NCT04298944

Start Date

March 11 2020

End Date

May 31 2022

Last Update

August 23 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins School of Medicine Division of Pediatric Nephrology

Baltimore, Maryland, United States, 21287